Informatics to enable routine personalized cancer therapy

$312,379U01FY2014CANIH

University Of Texas Hlth Sci Ctr Houston, Houston TX

Investigators

Elmer V Bernstamcontact Funda Meric-Bernstam

Linked publications & trials

Paper 38438731 Paper 38126764 Paper 37779428 Paper 37556023 Paper 37517365 Paper 37295905 Paper 37270847 Paper 37265425 Paper 37259805 Paper 37125861 Paper 37070849 Paper 37061987 Paper 37059834 Paper 37058010 Paper 37011025 Paper 36930859 Paper 36893753 Paper 36842301 Paper 36646803 Paper 36632846 Paper 36494311 Paper 36383913 Paper 36192554 Paper 36108661 Paper 36037567 Paper 35727698 Paper 35507888 Paper 35486638 Paper 35413124 Paper 35373284 Paper 35176457 Paper 35026411 Paper 34887213 Paper 34493590 Paper 34457132 Paper 34391699 Paper 34242968 Paper 34099825 Paper 33723371 Paper 33617938 Paper 33571468 Paper 33323389 Paper 33161056 Paper 32988960 Paper 32843426 Paper 32094155 Paper 32083997 Paper 31552380 Paper 31517177 Paper 31367649 Paper 30615938 Paper 30320296 Paper 30035249 Paper 29462132 Paper 29420467 Paper 29420224 Paper 29212833 Paper 29165790 Paper 29152071 Paper 29092956 Paper 28415679 Paper 27776519 Paper 27634896 Paper 27274018 Paper 27107438 Paper 27089234 Paper 27013523 Paper 27001195 Paper 26878762 Paper 26787237 Paper 26486734 Paper 26306235 Paper 26148707 Paper 26063744 Paper 26015395 Paper 26014291 Paper 25918555 Paper 25863335 Paper 25858285 Paper 25717412 Paper 25626406 Paper 25209923 Paper 25148578 Paper 24737606 Paper 24534473 Paper 24389657 Paper 24205039

Abstract

DESCRIPTION (provided by applicant): Genomic analysis of individual patients is now affordable and therapies targeted to specific molecular aberrations are being tested in clinical trials. However, even highly-specialized physicians at leading academic centers are not equipped to apply genomic information available in publically available sources to clinical- decision-making concerning individual patients. Our central hypothesis is that we can develop informatics tools to support personalized cancer treatment as standard of care rather than one off exceptions. We will: 1) implement a bioinformatics pipeline for processing molecular data into actionable profiles, 2) create and maintain a database of therapeutic implications of common genomic aberrations using automated processing of publically-available sources and 3) develop tools to summarize and present patient-specific advice to clinicians. These tools will be based on existing technologies and publicly available data sources. Once tested, we will make these tools available via appropriate open source license.

View original record on NIH RePORTER →